Zhang, X., Goel, V., & Robbie, G. J. (2019). Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis. J Clin Pharmacol.
Styl ChicagoZhang, Xiaoping, Varun Goel, a Gabriel J. Robbie. "Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis." J Clin Pharmacol 2019.
Citace podle MLAZhang, Xiaoping, Varun Goel, a Gabriel J. Robbie. "Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis." J Clin Pharmacol 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..